Arellano M;Winton E;Pan L;.High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloidleuke- mia older than 613 years.Cancer.0.42-433High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than ...
Reid W. Merryman, MD, discusses the impact of adding high-dose cytarabine to bendamustine and rituximab as an induction regimen for patients with mantle cell lymphoma.
Myeloid leukemia in children with Down syndrome (ML-DS) is a unique subtype of acute myeloid leukemia, distinguished by an earlier age of onset (under 4 years of age); somatic mutations of GATA1; hypersensitivity of leukemic blasts to cytarabine and other chemotherapeutic agents; lack of CNS in...
High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in a... Background/AimAlthough induction chemotherapy comprising high-dose cytarabine (HiDAC) in combination with idarubicin and etoposide or ‘ICE’...
网络大剂量阿糖胞苷 网络释义 1. 大剂量阿糖胞苷 ... High-dose immunoglobulin 丙种球蛋白High-dose Cytarabine大剂量阿糖胞苷high-dose methorexate 探讨大剂量甲氨蝶呤 ... dict.youdao.com|基于 1 个网页 例句
Dose-dense induction with the S-HAM regimen was compared to standard double induction therapy in adult patients with newly diagnosed acute myeloid leukemia. Patients were centrally randomized (1:1) between S-HAM (2nd chemotherapy cycle starting on day 8
OBJECTIVE:To monitor the concentration of cytarabine and uracil arabinoside in plasma or cerebrospinal fluid of children emergent lymphatic leukemia or malignant lympgoma patients.METHODS:The drug concentratmion was determined by HPLC.RESULTS:The concentr Key words: high dose cytarabine,monitor drug concent...
( 2010 ) Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy . Blood , 116 , 5818 – 5823 .Ravandi F, Cortes J, Faderl S, et al. Characteristics and outcome of patients...
8, 9 R-MegaCHOEP, in turn, is not superior to R-CHOEP-14 and is associated with significantly more toxicity.10 Likewise, rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (R‐HCVAD)/rituximab, high-dose methotrexate (HD-Mtx), and cytarabine (R‐MA)...
A Study of the Complete Response Rate with a Combination of High Dose Cytarabine and Cladribine in Refractory and Relapsed Acute LeukemiaAcute LeukemiaChemotherapy RegimenMortalityIntroduction: Acute leukemia covers a broad spectrum of hematological clonal diseases originating from the malignant transformation ...